Bremelanotide

🧮 Dose calculator

Hypoactive sexual desire disorder (premenopausal women) · Regimen source: FDA Vyleesi · 2.1

• • No more than one dose in 24 h; more than 8 doses per month not recommended. FDA Vyleesi · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Vyleesi · 8.1

  “For this reason, women should use effective contraception while taking VYLEESI and discontinue VYLEESI if pregnancy is suspected.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Vyleesi · 8.2

  “Risk Summary There is no information on the presence of bremelanotide or its metabolites in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Vyleesi · 8.4

  “The safety and effectiveness of VYLEESI have not been established in pediatric patients.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Vyleesi · 8.5

  “The safety and effectiveness of VYLEESI have not been established in geriatric patients.”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Vyleesi · 8.3

  “Contraception Use of VYLEESI during pregnancy is not recommended [see Use in Specific Populations ( 8.1 )].”